Yamada, Hidetada
Toko, Megumi
Nakamori, Masahiro
Ueno, Hiroki
Aoki, Shiro
Sugimoto, Tomohiro
Yasutomi, Hiroko
Nakamichi, Kazuo
Maruyama, Hirofumi
Article History
Received: 27 November 2023
Revised: 29 February 2024
Accepted: 13 March 2024
First Online: 19 March 2024
Declarations
:
: According to the instructions of the ethical review board of Hiroshima University Hospital, informed consent regarding the use of mefloquine was obtained from the patient’s family prior to the introduction of the therapy (authorization No. 133). This study is a retrospective observational single-case report, which does not require the approval of the institutional review boards of our institute; however, written consent was obtained from the patient’s family.
: The authors declare that they have no competing interests.